Lam G K
Bull Math Biol. 1989;51(3):293-309. doi: 10.1007/BF02460109.
The linear isobole that is commonly used as a reference for the study of interaction is derived from the interaction of an agent with itself. It is shown that the general use of the linear isobole in the study of the combined effects of mixtures of agents implies interaction between the agents whether the dose-effect curves of the agents are the same or not. It is difficult to generalize the interaction between two doses of the same agent to the interaction between two doses of different agents with different action mechanisms without the use of a mechanistic model. Predictions using non-interaction defined as independent action are generally different from those using linear isobole. A simple mechanistic framework based on the concept of common intermediate lesions is introduced in this paper to relate these two methods used for the analysis of synergism and antagonism. In this framework of lesion development, two agents that have no common intermediate lesion in their action will be non-interactive (referred to as independent action). When the two agents share a common intermediate, it is shown that the combined effect will follow the linear isobole (referred to as common action). This simple framework of analysis is applicable to the general study of interaction between two agents with different types of dose-effect curves.
常用于相互作用研究的线性等效线是由一种药物与其自身的相互作用推导而来的。结果表明,在研究药物混合物的联合效应时,无论药物的剂量 - 效应曲线是否相同,线性等效线的普遍使用都意味着药物之间存在相互作用。在不使用机制模型的情况下,很难将同一药物两剂量之间的相互作用推广到具有不同作用机制的两种不同药物两剂量之间的相互作用。使用定义为独立作用的非相互作用进行的预测通常与使用线性等效线的预测不同。本文引入了一个基于共同中间损伤概念的简单机制框架,以关联这两种用于分析协同作用和拮抗作用的方法。在这个损伤发展框架中,两种在作用中没有共同中间损伤的药物将是非相互作用的(称为独立作用)。当两种药物共享一个共同中间体时,结果表明联合效应将遵循线性等效线(称为共同作用)。这个简单的分析框架适用于对具有不同类型剂量 - 效应曲线的两种药物之间相互作用的一般研究。